Intelligence Search Intelligence Filter by: Industry Team Airport & AviationAutomotiveEmerging TechnologiesEnergy Food & BeverageHealth CareHospitality, Resort & GolfInsurance & Reinsurance Life SciencesManufacturingMedical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryFederal & State Energy RegulatoryFreight & Commuter RailGovernment Procurement Immigration, Nationality & Consular LawNHTSA & Motor Vehicle SafetyPolitical LawPublic Policy Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChina EuropeJapan Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & LitigationTrade Secret Noncompete Litigation Topic Accountable Care OrganizationsAmerica Invents Act (Patent Reform)Consumer Protection Act Corporate GovernanceDodd–Frank Wall Street ReformExport Control/Economic Sanctions Foreign Corrupt Practices Act (FCPA)Health Care ReformPersonalized Medicine Type ArticleBlog Post BookNewsletter VideoWhite Paper Featured All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared Foley Blogs: CFSL Bulletin Cleantech & Nano Dashboard Insights Labor & Employment Law Perspectives Personalized Medicine Bulletin PharmaPatents Renewable Energy Outlook Wisconsin Appellate Law 12345next A Look at the Myriad Gene Patent Claims and the USPTO Memo to Examiners on Myriad 17 June 2013 PharmaPatents Now that the Supreme Court has issued its decision in the “ACLU/Myriad” gene patents case (Association For Molecular Pathology v. Myriad Genetics, Inc.), people... Accommodations Under the ADAAA: Five Sure Ways to End Up in Court 17 June 2013 Labor & Employment Law Perspectives The ADA Amendments Act of 2008 (ADAAA) unquestionably imposes extensive requirements on employers and covers a broad range of medical conditions. As such, human... Next-Generation Manufacturing Invaded by Legal World 17 June 2013 Dashboard Insights Here at the Dashboard we try to avoid overt public relations on behalf of Foley & Lardner LLP. However, sometimes our firm is the one making the news. Often,... Supreme Court Says “Wait a Minute!” to Using Arbitration to Prevent Class Action Claims 17 June 2013 Labor & Employment Law Perspectives In the past couple of years, the United States Supreme Court has issued several arbitration decisions that many have thought might spell the roadmap for avoiding... Medical Device Industry Responds to FDA's Overseas Clinical Trial Proposed Rule 16 June 2013 Personalized Medicine Bulletin Guest Post By Jennifer M. Forde, Nathan A. Beaver and David L. Rosen In a resounding manner, members of the medical device industry recently filed comments reacting... Maximizing the Value of Pre-AIA Patent Applications Using First-to-File Regime – Part I 15 June 2013 Cleantech & Nano Authored by Emily Liu* and Tianran Yan The first-to-file provisions of the Leahy-Smith America Invents Act (AIA) took effect on March 16, 2013. The predominant... FDA's Plan to Regulate LDTs 14 June 2013 Personalized Medicine Bulletin Guest Post By David L. Rosen and Nathan A. Beaver In a remarkable move, the Food and Drug Administration recently indicated that it plans to take new steps to... U.S. Patent Office Issues Guidance to Examiners on Supreme Court's Myriad Decision 14 June 2013 Cleantech & Nano Today the USPTO issued guidance (PTO_Myriad_Guidelines) to Examiners on how to apply the Myriad Supreme Court decision to applications under examination. The... Isolated DNA Is Not Patent-Eligible 13 June 2013 Personalized Medicine Bulletin Today the U.S. Supreme Court in Ass’n for Molecular Pathology v. Myriad Genetics, Inc., __ U.S. __ (2013) (opinion here), held that genes and DNA fragments merely... Monsanto Averts Declaratory Judgment Suit 13 June 2013 Personalized Medicine Bulletin On June 10, 2013, the U.S. Court of Appeals for the Federal Circuit held that Monsanto’s representation that it would not pursue farmers and seed sellers for... 12345next Related 1 2 3
A Look at the Myriad Gene Patent Claims and the USPTO Memo to Examiners on Myriad 17 June 2013 PharmaPatents Now that the Supreme Court has issued its decision in the “ACLU/Myriad” gene patents case (Association For Molecular Pathology v. Myriad Genetics, Inc.), people...
Accommodations Under the ADAAA: Five Sure Ways to End Up in Court 17 June 2013 Labor & Employment Law Perspectives The ADA Amendments Act of 2008 (ADAAA) unquestionably imposes extensive requirements on employers and covers a broad range of medical conditions. As such, human...
Next-Generation Manufacturing Invaded by Legal World 17 June 2013 Dashboard Insights Here at the Dashboard we try to avoid overt public relations on behalf of Foley & Lardner LLP. However, sometimes our firm is the one making the news. Often,...
Supreme Court Says “Wait a Minute!” to Using Arbitration to Prevent Class Action Claims 17 June 2013 Labor & Employment Law Perspectives In the past couple of years, the United States Supreme Court has issued several arbitration decisions that many have thought might spell the roadmap for avoiding...
Medical Device Industry Responds to FDA's Overseas Clinical Trial Proposed Rule 16 June 2013 Personalized Medicine Bulletin Guest Post By Jennifer M. Forde, Nathan A. Beaver and David L. Rosen In a resounding manner, members of the medical device industry recently filed comments reacting...
Maximizing the Value of Pre-AIA Patent Applications Using First-to-File Regime – Part I 15 June 2013 Cleantech & Nano Authored by Emily Liu* and Tianran Yan The first-to-file provisions of the Leahy-Smith America Invents Act (AIA) took effect on March 16, 2013. The predominant...
FDA's Plan to Regulate LDTs 14 June 2013 Personalized Medicine Bulletin Guest Post By David L. Rosen and Nathan A. Beaver In a remarkable move, the Food and Drug Administration recently indicated that it plans to take new steps to...
U.S. Patent Office Issues Guidance to Examiners on Supreme Court's Myriad Decision 14 June 2013 Cleantech & Nano Today the USPTO issued guidance (PTO_Myriad_Guidelines) to Examiners on how to apply the Myriad Supreme Court decision to applications under examination. The...
Isolated DNA Is Not Patent-Eligible 13 June 2013 Personalized Medicine Bulletin Today the U.S. Supreme Court in Ass’n for Molecular Pathology v. Myriad Genetics, Inc., __ U.S. __ (2013) (opinion here), held that genes and DNA fragments merely...
Monsanto Averts Declaratory Judgment Suit 13 June 2013 Personalized Medicine Bulletin On June 10, 2013, the U.S. Court of Appeals for the Federal Circuit held that Monsanto’s representation that it would not pursue farmers and seed sellers for...